You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

palbociclib, ibrance, breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Palbociclib in Canadian Breast Cancer That Has Spread to Other

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 18, 2023

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • New York, New York
    Pfizer New York
Oct 11, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

Completed
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 21, 2022

Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCE®))

Recruiting
  • Breast Cancer
  • ARV-471
  • ARV-471 in combination with palbociclib (IBRANCE®)
  • Palo Alto, California
  • +16 more
Jan 30, 2023

Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
  • +2 more
Jan 12, 2023

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

Breast Cancer Female Trial in Belgium (Palbociclib)

Completed
  • Breast Cancer Female
  • Anderlecht, Belgium
  • +4 more
Jun 23, 2022

Ibrance Real World Insights

Completed
Has Results
  • Malignant Neoplasm of Breast
    • New York, New York
      Pfizer, Inc.
    May 10, 2022

    HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

    Completed
    • HER2-positive Breast Cancer
    • +5 more
    • Tucson, Arizona
    • +15 more
    Dec 22, 2022

    Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

    Recruiting
    • Cancer
    • +12 more
    • Tripoli, North Lebanon, Lebanon
    • +1 more
    Oct 5, 2023

    PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

    Not yet recruiting
    • PIK3CA Mutation
    • +7 more
    • (no location specified)
    Mar 7, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Active, not recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +20 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Breast Cancer Trial in Australia (OP-1250, Palbociclib)

    Recruiting
    • Breast Cancer
    • Westmead, New South Wales, Australia
    • +4 more
    Feb 23, 2022

    Breast Cancer Trial in United States (Letrozole, Tamoxifen, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Stamford, Connecticut
    • +10 more
    Jul 15, 2022

    Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

    Recruiting
    • Breast Cancer
    • Birmingham, Alabama
    • +3 more
    Apr 15, 2022

    Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

    Recruiting
    • Breast Cancer
    • Head and Neck Cancer
    • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
    • +3 more
    Dec 14, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

    Active, not recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +6 more
    • Atlanta, Georgia
    • +9 more
    Oct 12, 2022